Company / Interest Expense per Share
AMICUS THERAPEUTICS, INC. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.18
FY2023
5-year range
$0.12 / $0.18
FY2019-FY2023
Trend
+34.0%
vs FY2022
Sector context
#21 of 43
Health Care
What the data says
At $0.18, AMICUS THERAPEUTICS, INC.'s interest expense per share ranks #23 of 43 in the Health Care sector. Interest Expense per Share has increased for 4 consecutive years, from $0.08 in FY2019 to $0.18 in FY2023.
Based on SEC 10-K filings.
0.18 in FY2023 with a 5-year CAGR of +8.1%.
Increased from $0.12 to $0.18 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +27.2%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
#23 of 43 in Health CareTop 51% of 43This company $0.18 Sector average $18.61
▼
-99.0% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s interest expense per share has grown for 4 consecutive years.
- In FY2023, interest expense per share increased 34.0% year-over-year.
- Ranks #21 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.18 | +34.0% |
| FY2022 | $0.13 | +7.4% |
| FY2021 | $0.12 | +43.0% |
| FY2020 | $0.09 | +10.4% |
| FY2019 | $0.08 | -34.9% |
| FY2018 | $0.12 | -0.2% |
| FY2017 | $0.12 | +179.8% |
| FY2016 | $0.04 | +161.4% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026